BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 19, 2005
View Archived Issues
Affymax Series D Garners $60M To Boost Hematide
Affymax Inc. raised $60 million in a Series D financing to push along its Phase II candidate Hematide for anemia, which is expected to be studied in four separate trials by late fall. (BioWorld Today)
Read More
Lexicon Awarded $35M Grant For Genetic Library In Texas
Read More
XOMA Terminates $73M BPI Deal With Zephyr Sciences
Read More
CombinatoRx Out-Licenses Oncology Drug To HenKan
Read More
Genomic Health Inc.'s IPO: $75M For Diagnostic Tests
Read More
Other News To Note
Read More